author-photo

Sandip N. Chakraborty

University of Texas MD Anderson Cancer Center

11

Papers

301

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Combination of JAK2 and HSP90 inhibitors: an effective therapeutic option in drug-resistant chronic myelogenous leukemia.

2016 Genes & Cancer
Show All
- Source
- Cite
- Save
Citations (8)
HSP90 inhibitor AUY922 induces cell death by disruption of the Bcr-Abl, Jak2 and HSP90 signaling network complex in leukemia cells

2015 Genes & Cancer
Show All
- Source
- Cite
- Save
Citations (13)
C-Abl activates Janus kinase 2 in normal hematopoietic cells

2014 Journal of Biological Chemistry
Show All
- Source
- Cite
- Save
Citations (8)
Aurora Kinase-A Inactivates DNA Damage-Induced Apoptosis and Spindle Assembly Checkpoint Response Functions of p73

2012 Cancer Cell
Show All
- Source
- Cite
- Save
Citations (61)
Jak2 Regulates Bcr-Abl In CD34+ Cells From Imatinib Mesylate-Resistant CML Patients.

2010 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Destabilization of Bcr-Abl/Jak2 Network by a Jak2/Abl Kinase Inhibitor ON044580 Overcomes Drug Resistance in Blast Crisis Chronic Myelogenous Leukemia (CML)

2010 Genes & Cancer
Show All
- Source
- Cite
- Save
Citations (33)
Jak2 Phosphorylates Tyr 177 of Bcr-Abl Activating the Ras and PI-3 Kinase Pathways and Maintains Functional Levels of Bcr-Abl in Chronic Myelogenous Leukemia.

2009 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients

2009 Oncogene
Show All
- Source
- Cite
- Save
Citations (98)